Abcellera Biologics • Robinhood Token

Robinhood Stock Tokens 第 183 号系列，追踪 AbCellera Biologics Inc.（ISIN CA00288U1066，Bloomberg Ticker ABCL，主要上市地 纳斯达克）。原件 Description of the Underlying 段首句逐字：「The Underlying is a share of AbCellera Biologics Inc..」原件另载：所属行业 Biotechnology。

本条的发行文件为该系列专属的 Final Terms（A 级，发行人官网法律页），与同一 Programme 项下各系列共用的 Base Prospectus（FMA 批准，2026 年 6 月 25 日，169 页）合并构成完整招股说明书。

产品性质（Base Prospectus p9 逐字）：「debt securities which are securitised in the form of cryptographic tokens and constitute ledger-based securities (Registerwertrechte) according to Article 973d et. seqq. of the CO. The Products shall be created by the Issuer by means of a registration in the smart contract-based securities ledger according to Article 973d(2) of the CO.」p71 另称「Each Product is a unit of a fully collateralised tracker certificate」。

与底层的关系（发行人官网逐字）：「The Product provides economic exposure to underlying securities but does not grant investors any legal or beneficial rights in, or against the issuer of, those underlying securities.」担保安排（Final Terms 逐字）：「The Collateral primarily comprises the Underlying. The Collateral shall also comprise cash and Eligible Financial Instruments in the circumstances described in the Terms and Conditions.」分红不派现金，改以 multiplier 机制自动再投资，代币乘数随之上升。

链上登记：合约地址 0x3139D77Ace0cbAA5bDfD38bD1F1911a794AF0B0e，部署于 Robinhood Chain（chainId 4663），ERC-20、18 位小数。

发行规模：Final Terms 载 Total Issue Volume 为 up to USD 5,000,000,000（发行上限，非存量规模）；发行人未披露实际存量，故规模数值留空。

交易场所：Final Terms 逐字「the Issuer has not arranged for the Products to be admitted to trading or to be listed (nor made any application in relation thereto) on any regulated market, third country market, small or medium-sized enterprises growth market or multilateral trading facility, nor any other stock exchange, organised trading facility, DLT trading facility, or equivalent」。

「Non-Exempt Offer」项逐字：「Non-Exempt Offer Applicable. An offer of the Products may be made by any Authorised Offeror(s) other than pursuant to Article 1(4) of the Prospectus Regulation in Liechtenstein, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden and the Netherlands and any other Member State where the current Base Prospectus (and any supplements) have been notified to the competent authority in that Member State pursuant to the Prospectus Regulation (each, a “Non-Exempt Offer Jurisdiction”)」。

该句尾部另有一句开放式兜底「and any other Member State where the current Base Prospectus (and any supplements) have been notified to the competent authority in that Member State」——它指向的是一个无具名对象的开放集合，装不进任何枚举，故只在此留痕、不填入任何值。
发售国清单与 jurisdiction（＝列支敦士登，FMA 批准招股说明书）正交，两者不得互相推定（§2.5.1）。

Final Terms 逐字：「The Products do not have a predetermined fixed maturity date. Instead, the Products may or shall be redeemed in accordance with the redemption procedures described in the Terms and Conditions.」

发行人官网 FAQ 逐字：「You can sell your Stock Tokens from time to time in the secondary market. You can also redeem them directly with the Issuer, where there is no authorized participant (a firm that processes redemptions on investors' behalf), subject to completing the Issuer's KYC/AML (identity verification) processes.」

铸造／销毁窗口（发行人官网 docs.robinhood.com/chain/stock-tokens 逐字）：「Market makers can place orders to mint and burn Stock Tokens during the following window: Monday 02:00 CET/CEST – Saturday 02:00 CET/CEST ... Outside this window, minting and burning is not supported. End users may still buy and sell Stock Tokens on-chain outside the tokenization window.」